Zymeworks Inc. Common Stock (ZYME) — Capital Reinvestment Ratio
Zymeworks Inc. Common Stock (ZYME) has a Capital Reinvestment Ratio of 0.07x as of June 2025, meaning it reinvests 0% of its operating cash flow ($12.07 Million) in capital expenditures ($884.00K). See Zymeworks Inc. Common Stock balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Zymeworks Inc. Common Stock Capital Reinvestment Ratio (2017–2022)
This chart tracks Zymeworks Inc. Common Stock's Capital Reinvestment Ratio across 3 annual periods. Check Zymeworks Inc. Common Stock (ZYME) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Zymeworks Inc. Common Stock (2017–2022)
Year-by-year Capital Reinvestment Ratio for Zymeworks Inc. Common Stock from 2017 to 2022. For live market cap and broader valuation context, see ZYME company net worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2022 | 0.09x | $144.11 Million | $13.12 Million | ▼ -35.6% |
| 2018 | 0.14x | $24.18 Million | $3.42 Million | ▼ -99.0% |
| 2017 | 14.25x | $219.00K | $3.12 Million | — |